Reputations, Digital, and Job Opportunities at the Arthur Page Conference

In addition to announcing a new corp comms model, the Arthur W. Page Society is having a spring conference in NYC that wraps up today. Yesterday, I sat in on the “CEO Spotlight,” which was placed on healthcare/pharmaceutical company Novartis.

Novartis faces a dilemma, according to CEO Joe Jimenez. “We’re ranked first as Fortune magazine’s most admired pharmaceutical company, but the whole industry suffers from a poor reputation,” he said. He bemoaned that “public trust of pharma even ranks below oil and tobacco.”

The key factor driving pharma’s bad reputation is “the high cost of medications, and the public thinks all the industry cares about is making profits,” Jimenez said.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in